Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SNCA | P37840 | 1/20 | 0.54 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.50 |
| ▸ | ADRB2 | P07550 | 1/20 | 0.47 |
| ▸ | ADRB1 | P08588 | 1/20 | 0.47 |
| ▸ | ADRB3 | P13945 | 1/20 | 0.47 |
| ▸ | CA1 | P00915 | 2/20 | 0.46 |
| ▸ | CA2 | P00918 | 2/20 | 0.46 |
| ▸ | MAPT | P10636 | 3/20 | 0.45 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.45 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.45 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.44 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.44 |
| ▸ | LMNA | P02545 | 2/20 | 0.44 |
| ▸ | TSHR | P16473 | 1/20 | 0.44 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.44 |
| ▸ | APEX1 | P27695 | 1/20 | 0.44 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.44 |
| ▸ | RECQL | P46063 | 1/20 | 0.44 |
| ▸ | MEN1 | O00255 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8839201 | 0.91 | KMT2A (0.51) | SNCACYP3A4CA1CA2MAPT | |
| SCHEMBL548224 | 0.89 | SNCA (0.52) | SNCACYP3A4ADRB2ADRB1ADRB3 | |
| SCHEMBL175786 | 0.86 | SNCA (0.67) | SNCACYP3A4ADRB2ADRB1ADRB3 | |
| SCHEMBL7661375 | 0.84 | HDAC1 (0.42) | CYP3A4MAPTTDP1HDAC1ALDH1A1 | |
| SCHEMBL28740076 | 0.83 | SNCA (0.57) | SNCACYP3A4MAPTALDH1A1HSD17B10 | |
| SCHEMBL2705494 | 0.81 | SNCA (0.58) | SNCACYP3A4ADRB2ADRB1ADRB3 | |
| SCHEMBL6063574 | 0.81 | CA1 (0.49) | CA1CA2MAPTTDP1L3MBTL1 | |
| SCHEMBL11048573 | 0.81 | CA1 (0.61) | SNCACYP3A4CA1CA2MAPT | |
| SCHEMBL9270334 | 0.81 | SNCA (0.58) | SNCACYP3A4ADRB2ADRB1ADRB3 | |
| SCHEMBL8839061 | 0.81 | SNCA (0.58) | SNCACYP3A4ADRB2ADRB1ADRB3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0392514-B1 | Organic glass with high refractive index | DAISO CO LTD (JP) | 1994-10-12 | — | — | EP | claimed |
| US-5051488-A | A copolymer of diallyl isophthalate, allyl benzoate or methallyl benzoate and a diester of maleic acid | DAISO CO., LTD. (JP) | 1991-09-24 | — | — | US | claimed |
| EP-0392514-A2 | Organic glass with high refractive index | DAISO CO., LTD. (JP) | 1990-10-17 | — | — | EP | claimed |
| US-20230002520-A1 | CURABLE COMPOSITION, CURED PRODUCT, AND METHOD FOR PRODUCING CURED PRODUCT | TOKYO OHKA KOGYO CO., LTD. (JP) | 2023-01-05 | — | — | US | disclosed |
| US-8034933-B2 | graft v. host disease, arthritis, rheumatoid arthritis, inflammatory bowel disease, atopic dermatitis, psoriasis, asthma, allergies or multiple sclerosis; human immunodeficiency viricides | SCHERING CORPORATION (US) | 2011-10-11 | — | — | US | disclosed |
| US-7442703-B2 | Piperidine derivatives useful as CCR5 antagonists | SCHERING CORPORATION (US) | 2008-10-28 | — | — | US | disclosed |
| US-20080214575-A1 | PIPERIDINE DERIVATIVES USEFUL AS CCR5 ANTAGONISTS | SCHERING CORPORATION | 2008-09-04 | — | — | US | disclosed |
| US-7384948-B2 | Piperidine derivatives useful as CCR5 antagonists | SCHERING CORPORATION (US) | 2008-06-10 | — | — | US | disclosed |
| EP-0392514-B1 | Organic glass with high refractive index | DAISO CO LTD (JP) | 1994-10-12 | — | — | EP | disclosed |
| US-5051488-A | A copolymer of diallyl isophthalate, allyl benzoate or methallyl benzoate and a diester of maleic acid | DAISO CO., LTD. (JP) | 1991-09-24 | — | — | US | disclosed |
| EP-0392514-A2 | Organic glass with high refractive index | DAISO CO., LTD. (JP) | 1990-10-17 | — | — | EP | disclosed |
| US-4282203-A | Hair lacquer and hair lotion compositions containing a copolymer having units of a vinyl allyl or methally ester of an α- or β-cyclic carboxylic acid | L'OREAL (FR) | 1981-08-04 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080214575-A1 | PIPERIDINE DERIVATIVES USEFUL AS CCR5 ANTAGONISTS | CCR5, CCR10, CXCR3 | SNCA 2692/4885CYP3A4 860/4885ADRB2 209/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.